指南与共识骨肌技术与安全CTPET

过去十年骨单光子发射计算机断层/计算机断层在癌症诊疗中的应用:系统综述与Meta分析及对未来工作的建议

Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work.
指南 / 共识 · Nucl Med Commun · 2021-01-01

该系统综述与Meta分析纳入截至2020年8月30日的文献,最终12篇进入Meta分析,评估SPECT/CT对全身骨显像检出的不确定骨病灶的鉴别能力;汇总敏感度93.0%(95%CI 0.91-0.95)、特异度96.0%(95%CI 0.94-0.97),但因成像方案、随访时长和判读评分方法不一而存在异质性,作者建议标准化阈值、方法学及报告与判读标准。

要点

  • SPECT/CT用于鉴别全身骨显像检出的不确定骨病灶,汇总敏感度93.0%、特异度96.0%。
  • 纳入研究在成像方案、随访时长和SPECT/CT判读评分方法上存在异质性。
  • 作者建议标准化SPECT/CT阈值、方法学以及报告与判读标准。

核心结论

  • 靶向SPECT/CT提高了诊断骨转移的特异度,但需努力标准化SPECT/CT阈值、方法学并统一报告与判读标准。

研究设计与样本

  • 系统综述与Meta分析,检索相关电子数据库截至2020年8月30日,经偏倚风险与合格性评估后12篇文章纳入Meta分析。
  • 以组织病理学检查或临床与影像随访为参考标准,计算SPECT/CT诊断不确定骨病灶的敏感度和特异度。

关键影像表现/征象

  • 全身骨显像虽广泛用于肿瘤骨转移检测且敏感,但特异度相对较低,其检出的不确定骨病灶造成诊断困境并妨碍后续管理。

诊断标准与关键数值

  • SPECT/CT诊断不确定骨病灶的汇总敏感度为93.0%(95%CI 0.91-0.95),汇总特异度为96.0%(95%CI 0.94-0.97)。

临床应用与阅片要点

  • 作者建议标准化SPECT/CT的阈值、方法学以及报告与判读标准,并就未来工作提出建议。

局限性

  • 纳入文章因成像方案、随访时长和SPECT/CT结果判读评分方法不一而存在异质性。
  • 异质性对准确解读SPECT/CT真实诊断能力构成挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Skeletal whole-body scintigraphy (WBS), although widely used as a sensitive tool for detecting metastatic bone disease in oncology cases, has relatively low specificity. Indeterminate bone lesions (IBLs) detected by WBS cause a diagnostic dilemma, which hampers further management plans. In the advent of hybrid imaging, single-photon emission computed tomography/computed tomography (SPECT/CT) has been gaining popularity as a tool to improve the characterisation of IBLs detected by WBS. As yet, there has not been a systematic review to objectively evaluate the diagnostic capabilities of SPECT/CT in this area. We conducted a systematic review of relevant electronic databases up to 30 August 2020. The outcomes of interest were the reporting of SPECT/CT to identify benign and malignant IBLs and the calculation of the sensitivity and specificity of the index test, based on histopathological examination or clinical and imaging follow-up as the reference standard. After the risk of bias and eligibility assessment, 12 articles were identified and synthesised in the meta-analysis. The pooled sensitivity and specificity of SPECT/CT for diagnosing IBLs are 93.0% [95% confidence interval (CI) 0.91-0.95] and 96.0% (95% CI 0.94-0.97), respectively. There was heterogeneity of the articles due to variable imaging protocols, duration of follow-up and scoring methods for interpreting the SPECT/CT results. The heterogeneity poses a challenge for accurate interpretation of the true diagnostic capability of SPECT/CT. In conclusion, targeted SPECT/CT improves the specificity of diagnosing bone metastases, but efforts need to be made to standardise the thresholds for SPECT/CT, methodology, as well as harmonising the reporting and interpretation criteria. We also make some recommendations for future works.

来源:Nucl Med Commun,查看原文。版权归原作者所有。

引用

  1. Mohd Rohani MF, Zanial AZ, Suppiah S, et al. Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work. Nucl Med Commun. 2021. PMID: 33165258. doi:10.1097/MNM.0000000000001306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。